[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"market-0x160693bb96f6bdc1c34006333f36bf590e78b52d33c47a2e8ccc2293ee5dfdcb":3,"market-hist-0x160693bb96f6bdc1c34006333f36bf590e78b52d33c47a2e8ccc2293ee5dfdcb:padcuw":23},{"market":4,"consensus":8,"positions":19,"truncated":20,"whaleCount":12,"meta":21},{"conditionId":5,"question":6,"slug":7,"eventSlug":7,"category":8,"status":9,"endDateIso":10,"volumeNum":11,"liquidityNum":12,"active":12,"closed":13,"outcomes":14},"0x160693bb96f6bdc1c34006333f36bf590e78b52d33c47a2e8ccc2293ee5dfdcb","FDA approves Elevar Therapeutics' Rivoceranib + camrelizumab?","fda-approves-elevar-therapeutics-rivoceranib-camrelizumab-07-23-2026",null,"closed","2026-07-23T00:00:00Z",1782.786077,0,1,[15,17],{"name":16,"price":12},"Yes",{"name":18,"price":13},"No",[],false,{"generatedAt":22},"2026-10-01T17:20:18.583Z",{"points":24,"whaleEntryAt":8,"whaleAvgPrice":8,"insufficientData":25,"meta":26},[],true,{"generatedAt":27},"2026-10-01T17:20:18.585Z"]